<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref23">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Denis</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Acosta-Ramirez</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hamelin</surname>
    <given-names>M. E.</given-names>
   </name>
   <name>
    <surname>Koukavica</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Baz</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2008</year>). 
  <article-title>Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform</article-title>. 
  <source>Vaccine</source>
  <volume>26</volume>, 
  <fpage>3395</fpage>â€“
  <lpage>3403</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2008.04.052</pub-id>, PMID: 
  <?supplied-pmid 18511159?>
  <pub-id pub-id-type="pmid">18511159</pub-id>
 </mixed-citation>
</ref>
